NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis?

DINCER D., DUMAN A., DIKICI H., ARICI C., Suleymanlar I., ISITAN F.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, cilt.60, sa.5, ss.546-548, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 60 Sayı: 5
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1111/j.1742-1241.2006.00794.x
  • Dergi Adı: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.546-548
  • Anahtar Kelimeler: NSAID, upper gastrointestinal bleeding, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, RHEUMATOID-ARTHRITIS, ULCER PREVENTION, GASTRIC-ULCER, DOUBLE-BLIND, MISOPROSTOL, OSTEOARTHRITIS, MULTICENTER, CELECOXIB
  • Akdeniz Üniversitesi Adresli: Evet

Özet

The purposes of this study were to evaluate the effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on acute nonvaricose upper gastrointestinal bleeding (ANUGIB) and establish whether the NSAID-prescribing physicians take precautions to prevent or reduce GI ulcerations.